Traceable Predictive Analytics: The Competitive Advantage for Pharmaceutical Industry Profits

Predictive analytics provides key advantages to businesses seeking to both forecast future business outcomes and to prevent potentially avoidable disasters, which have been well-documented in a wide variety of media, most notably in Moneyball. Although the pharmaceutical industry is no exception to the rule in this regard, pharma requires a specific set of data, integration, and analytic requirements to fully take advantage of predictive analytics.

The pharmaceutical industry faces a variety of key challenges based on the complexity of its business model that, in conjunction, represent a unique set of circumstances that must be managed to ensure business success. To take full advantage of predictive analytics, pharmaceutical companies must effectively account for regulatory, environmental, manufacturing, and business customization issues.

To read the rest of this report, please fill out the download form.

Microsoft Word - RT-A0253-PredictiveAnalyticsPharma-HP-Final.doc

About Hyoun Park

Hyoun Park is the Chief Research Officer of Blue Hill Research where he oversees day-to-day research operations, delivery and methodology focused on vendor and technology selection. In addition, Park covers analytics and enterprise mobility technologies as a noted advisor, social influencer, and practitioner. Park has been named as a top 10 Big Data, analytics, and mobility influencer including quotes in USA Today, the Los Angeles Times, and a wide variety of industry media sources. Over the past 20 years, Park has been on the cutting edge of web, social, cloud, and mobile technologies in both startup and enterprise roles. Park holds a Masters of Business Administration from Boston University and graduated with a Bachelor of Arts in Women's and Gender Studies from Amherst College.
Posted on September 26, 2016 by Hyoun Park

Download Your Report

First Name:
Last Name: